New Trial Results Question Standard Treatment Plan for Rheumatoid Arthritis
(WorldNews Netherlands)

In a clinical trial of patients with rheumatoid arthritis, treatment with a drug called upadacitinib provided greater benefits than methotrexate, the most commonly used initial therapy for rheumatoid arthritis. Upadacitinib inhibits certain proteins called Janus kinase enzymes that are involved in inflammation. It`s approved for treating patients with rheumatoid arthritis, but only after they`ve tried methotrexate. In the study published in Arthritis & Rheumatology, 947...